Evidence map›Paper›PMID 30178239›Full record

ArticlePediatric nephrology (Berlin, Germany)2018

Structural renal abnormalities in the DICER1 syndrome: a family-based cohort study.

Nicholas E Khan, Alexander Ling, Molly E Raske, Laura A Harney, Ann G Carr, Amanda Field, Anne K Harris, Gretchen M Williams, Louis P Dehner, Yoav H Messinger and 3 more

Registry-linked trialAbstract read
In one paragraph

Article in Pediatric nephrology (Berlin, Germany), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03382158 (International Pleuropulmonary Blastoma/DICER1 Registry), which is not on this map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03382158 recruitingnot on this map

International Pleuropulmonary Blastoma/DICER1 Registry (for PPB, DICER1 and Associated Conditions)

Typeobservational_patient_registrySponsorChildren's Hospitals and Clinics of MinnesotaRan2016 to 2035Enrolled3,400ConditionsPleuropulmonary Blastoma, Sertoli-Leydig Cell Tumor, DICER1 Syndrome, Cystic Nephroma
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Guideline
  2. Expanding the Molecular Data ofHuman mutation · 2026
    Article
  3. Review
  4. DICER1-Related Tumor Predisposition: Identification of At-risk Individuals and Recommended Surveillance Strategies.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Article
  5. Article
  6. DICER1 tumor predisposition syndrome: an evolving story initiated with the pleuropulmonary blastoma.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2022
    Review
  7. Article
  8. Article
  9. Imaging of DICER1 syndrome.Pediatric radiology · 2019
    Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 1 country.

Nicholas E KhanClinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, 20850, USA.
Alexander LingClinical Center Department of Radiology and Imaging Sciences, National Institutes of Health, Bethesda, MD, 20892, USA.
Molly E RaskeDepartment of Radiology, Children's Minnesota, Minneapolis, MN, 55404, USA.
Laura A HarneyWestat, Inc., Rockville, MD, 20850, USA.
Ann G CarrWestat, Inc., Rockville, MD, 20850, USA.
Amanda FieldDivision of Pathology and Center for Clinical and Immunology Research, Children's National Health System, Washington, DC, 20010, USA.
Anne K HarrisCancer and Blood Disorders, Children's Minnesota, Minneapolis, MN, 55404, USA.
Gretchen M WilliamsCancer and Blood Disorders, Children's Minnesota, Minneapolis, MN, 55404, USA.
Louis P DehnerDepartment of Pathology and Immunology, Washington University Medical Center, St. Louis, MO, 63130, USA.
Yoav H MessingerCancer and Blood Disorders, Children's Minnesota, Minneapolis, MN, 55404, USA.
D Ashley HillDivision of Pathology and Center for Clinical and Immunology Research, Children's National Health System, Washington, DC, 20010, USA.
Kris Ann P SchultzCancer and Blood Disorders, Children's Minnesota, Minneapolis, MN, 55404, USA.
Douglas R StewartClinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, 20850, USA. drstewart@mail.nih.gov.ORCID 0000-0001-8193-1488
Art Institutes International Minnesota · USChildren’s Minnesota - St. Paul Hospital · USChildren's National · USWestat (United States) · USChildren's Minnesota · USNational Cancer Institute · USNational Institutes of Health Clinical Center · USRush University Medical Center · USWashington University Medical Center · US

Funding

DICER1 and the Pleuropulmonary Blastoma Family Cancer SyndromeR01CA143167 · NCI · CHILDREN'S RESEARCH INSTITUTE · PI HILL, DANA ASHLEY · 2010 to 2020
$3.7M
Intramural NIH HHS Z99 CA999999NCI NIH HHS 2R01CA143167NCI NIH HHS R01 CA143167NULL Z99 CA999999
6 · The paper itself

Abstract

backgroundThe DICER1 syndrome is a tumor-predisposition disorder caused by germline pathogenic variation in DICER1 and is associated with cystic nephroma and other renal neoplasms. Dicer1 mouse and rare human DICER1 syndrome case reports describe structural kidney and collecting system anomalies. We investigated renal function and the frequency of structural abnormalities of the kidney and collecting system in individuals with germline loss-of-function variants in DICER1.

methodsIn this family-based cohort study, prospectively ascertained germline DICER1-mutation carriers (DICER1-carriers) and unaffected family controls were evaluated at the National Institutes of Health Clinical Center with renal ultrasound and comprehensive laboratory testing. Two radiologists reviewed the imaging studies from all participants for structural abnormalities, cysts, and tumors.

resultsEighty-nine DICER1-carriers and 61 family controls were studied. Renal cysts were detected in 1/33 DICER1-carrier children without history of cystic nephroma. Similar proportions of adult DICER1-carriers (8/48; 17%) and controls (11/50; 22%) had ultrasound-detected renal cysts (P = 0.504). 8/89 (9%) DICER1-carriers harbored ultrasound-detected structural abnormalities of varying severity within the collecting system or kidney, nephrolithiasis, or nephrocalcinosis. None of the family controls (0/61) had similar findings on ultrasound (P = 0.02). No meaningful differences in renal laboratory values between DICER1-carriers and unaffected family controls were observed.

conclusionsOur report is the first to systematically characterize renal function and anatomy in a large prospective cohort of DICER1-carriers and DICER1-negative family controls. DICER1-carriers may be at increased risk of structural anomalies of the kidney or collecting system. The role for DICER1 in renal morphogenesis merits additional investigation.

Indexed as

AdolescentChildChild, PreschoolDEAD-box RNA HelicasesFemaleGenetic TestingGerm-Line MutationHeterozygoteHumansInfantKidneyKidney Diseases, CysticKidney NeoplasmsLoss of Function MutationMalePrevalenceDEAD-box RNA HelicasesDICER1 protein, humanRibonuclease IIICollecting systemDICER1KidneyRenal cystStructural abnormality

Identifiers

PMID30178239
PMCPMC6203641
OpenAlexW2892363889

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.